| 3.8 |
11.3 |
GO:0045362 |
regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 2.6 |
7.9 |
GO:0002232 |
leukocyte chemotaxis involved in inflammatory response(GO:0002232) |
| 2.5 |
7.5 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 2.1 |
6.2 |
GO:0045082 |
positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 1.9 |
5.7 |
GO:1901076 |
positive regulation of engulfment of apoptotic cell(GO:1901076) |
| 1.8 |
5.4 |
GO:0002894 |
positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 1.8 |
5.4 |
GO:0035623 |
renal glucose absorption(GO:0035623) |
| 1.8 |
10.5 |
GO:0061143 |
alveolar primary septum development(GO:0061143) |
| 1.6 |
6.5 |
GO:0090346 |
cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 1.6 |
33.6 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 1.6 |
6.3 |
GO:0046271 |
phenylpropanoid catabolic process(GO:0046271) |
| 1.5 |
4.6 |
GO:0032581 |
ER-dependent peroxisome organization(GO:0032581) |
| 1.5 |
4.5 |
GO:2000627 |
regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
| 1.5 |
4.5 |
GO:0002731 |
negative regulation of dendritic cell cytokine production(GO:0002731) |
| 1.5 |
1.5 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 1.4 |
5.6 |
GO:0003331 |
regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 1.3 |
12.0 |
GO:0046618 |
drug export(GO:0046618) |
| 1.3 |
6.6 |
GO:0016185 |
synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 1.3 |
6.6 |
GO:2000110 |
negative regulation of macrophage apoptotic process(GO:2000110) |
| 1.3 |
6.5 |
GO:0070837 |
dehydroascorbic acid transport(GO:0070837) |
| 1.3 |
6.3 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 1.3 |
3.8 |
GO:0007506 |
gonadal mesoderm development(GO:0007506) |
| 1.3 |
3.8 |
GO:0070902 |
mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 1.2 |
6.2 |
GO:1904245 |
regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
| 1.2 |
3.5 |
GO:2000397 |
regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 1.1 |
3.4 |
GO:0043317 |
regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) |
| 1.1 |
3.4 |
GO:0051596 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 1.1 |
1.1 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) transcription initiation from mitochondrial promoter(GO:0006391) |
| 1.1 |
1.1 |
GO:0008211 |
glucocorticoid metabolic process(GO:0008211) |
| 1.1 |
7.7 |
GO:0045079 |
negative regulation of chemokine biosynthetic process(GO:0045079) |
| 1.1 |
4.4 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 1.1 |
3.3 |
GO:1900075 |
regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 1.1 |
4.4 |
GO:1905225 |
response to thyrotropin-releasing hormone(GO:1905225) |
| 1.1 |
3.2 |
GO:1900738 |
positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 1.1 |
7.5 |
GO:1902162 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 1.1 |
5.3 |
GO:0097460 |
ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 1.0 |
5.2 |
GO:0014826 |
vein smooth muscle contraction(GO:0014826) |
| 1.0 |
3.1 |
GO:1903947 |
regulation of heart looping(GO:1901207) positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903762) positive regulation of ventricular cardiac muscle cell action potential(GO:1903947) positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905026) positive regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905033) |
| 1.0 |
1.0 |
GO:0046320 |
regulation of fatty acid oxidation(GO:0046320) |
| 1.0 |
10.2 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 1.0 |
4.1 |
GO:1904106 |
protein localization to microvillus(GO:1904106) |
| 1.0 |
5.0 |
GO:1904845 |
response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 1.0 |
2.9 |
GO:2000502 |
negative regulation of natural killer cell chemotaxis(GO:2000502) |
| 1.0 |
1.0 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 1.0 |
2.9 |
GO:0090381 |
regulation of heart induction(GO:0090381) regulation of heart induction by canonical Wnt signaling pathway(GO:0100012) |
| 1.0 |
1.0 |
GO:2000866 |
positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
| 1.0 |
6.7 |
GO:0010133 |
proline catabolic process to glutamate(GO:0010133) |
| 1.0 |
4.8 |
GO:0009440 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.9 |
3.7 |
GO:0090301 |
regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.9 |
5.6 |
GO:0070221 |
sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.9 |
18.4 |
GO:1990573 |
potassium ion import across plasma membrane(GO:1990573) |
| 0.9 |
3.5 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.9 |
2.6 |
GO:0045608 |
negative regulation of auditory receptor cell differentiation(GO:0045608) |
| 0.9 |
1.7 |
GO:1902003 |
beta-amyloid formation(GO:0034205) regulation of beta-amyloid formation(GO:1902003) |
| 0.8 |
0.8 |
GO:0009447 |
putrescine catabolic process(GO:0009447) polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.8 |
3.3 |
GO:0042631 |
cellular response to water deprivation(GO:0042631) |
| 0.8 |
6.5 |
GO:1902998 |
regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 0.8 |
3.2 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.8 |
4.0 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.8 |
2.4 |
GO:0045448 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.8 |
2.3 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.8 |
1.6 |
GO:0090031 |
positive regulation of steroid hormone biosynthetic process(GO:0090031) |
| 0.8 |
5.4 |
GO:0051006 |
positive regulation of lipoprotein lipase activity(GO:0051006) |
| 0.8 |
13.8 |
GO:1901750 |
leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.8 |
3.8 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.8 |
3.8 |
GO:0051970 |
negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.8 |
6.1 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.8 |
3.0 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.7 |
3.0 |
GO:1903719 |
regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.7 |
2.2 |
GO:0003168 |
Purkinje myocyte differentiation(GO:0003168) cardiac pacemaker cell fate commitment(GO:0060927) atrioventricular node cell fate commitment(GO:0060929) |
| 0.7 |
6.5 |
GO:0031444 |
slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.7 |
0.7 |
GO:0042559 |
pteridine-containing compound biosynthetic process(GO:0042559) |
| 0.7 |
2.2 |
GO:0014724 |
regulation of twitch skeletal muscle contraction(GO:0014724) regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
| 0.7 |
6.5 |
GO:0006572 |
tyrosine catabolic process(GO:0006572) |
| 0.7 |
2.1 |
GO:0014707 |
branchiomeric skeletal muscle development(GO:0014707) |
| 0.7 |
0.7 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.7 |
1.4 |
GO:0002086 |
diaphragm contraction(GO:0002086) |
| 0.7 |
0.7 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.7 |
4.9 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.7 |
2.8 |
GO:0010900 |
negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.7 |
3.5 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.7 |
0.7 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
| 0.7 |
8.3 |
GO:0046149 |
porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.7 |
3.4 |
GO:0097029 |
mature conventional dendritic cell differentiation(GO:0097029) |
| 0.7 |
2.1 |
GO:0002541 |
activation of plasma proteins involved in acute inflammatory response(GO:0002541) positive regulation of fibrinolysis(GO:0051919) |
| 0.7 |
6.2 |
GO:0033033 |
negative regulation of myeloid cell apoptotic process(GO:0033033) |
| 0.7 |
2.0 |
GO:0009080 |
alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
| 0.7 |
2.0 |
GO:0000494 |
box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 0.7 |
5.4 |
GO:0033216 |
ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.7 |
4.0 |
GO:0015722 |
canalicular bile acid transport(GO:0015722) |
| 0.7 |
2.0 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.7 |
2.6 |
GO:0000412 |
histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.7 |
2.0 |
GO:0072039 |
regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) negative regulation of somatic stem cell population maintenance(GO:1904673) |
| 0.6 |
1.9 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.6 |
8.4 |
GO:0019375 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.6 |
3.8 |
GO:0072240 |
DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
| 0.6 |
1.3 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.6 |
3.1 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.6 |
3.8 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.6 |
1.9 |
GO:0072428 |
signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.6 |
0.6 |
GO:0039689 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.6 |
1.2 |
GO:0002266 |
follicular dendritic cell activation(GO:0002266) |
| 0.6 |
18.3 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.6 |
3.0 |
GO:0042357 |
thiamine diphosphate metabolic process(GO:0042357) |
| 0.6 |
4.2 |
GO:2000860 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.6 |
9.1 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.6 |
1.2 |
GO:0060796 |
regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
| 0.6 |
4.8 |
GO:0010898 |
positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.6 |
1.2 |
GO:0038162 |
erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.6 |
0.6 |
GO:0072577 |
endothelial cell apoptotic process(GO:0072577) |
| 0.6 |
14.0 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.6 |
2.9 |
GO:1990523 |
bone regeneration(GO:1990523) |
| 0.6 |
3.4 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 0.6 |
3.4 |
GO:1902499 |
positive regulation of protein autoubiquitination(GO:1902499) |
| 0.6 |
2.9 |
GO:0042412 |
taurine biosynthetic process(GO:0042412) |
| 0.6 |
4.6 |
GO:0000066 |
mitochondrial ornithine transport(GO:0000066) |
| 0.6 |
0.6 |
GO:0017055 |
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 0.6 |
0.6 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.6 |
1.7 |
GO:0046081 |
dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 0.6 |
2.2 |
GO:0042351 |
'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 0.6 |
2.2 |
GO:0032571 |
response to vitamin K(GO:0032571) |
| 0.6 |
3.3 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.5 |
1.1 |
GO:0006114 |
glycerol biosynthetic process(GO:0006114) |
| 0.5 |
1.6 |
GO:0070676 |
intralumenal vesicle formation(GO:0070676) |
| 0.5 |
3.2 |
GO:0061624 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.5 |
0.5 |
GO:0003197 |
endocardial cushion development(GO:0003197) |
| 0.5 |
16.1 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.5 |
0.5 |
GO:0044246 |
regulation of collagen metabolic process(GO:0010712) regulation of multicellular organismal metabolic process(GO:0044246) |
| 0.5 |
4.8 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.5 |
2.6 |
GO:0006808 |
regulation of nitrogen utilization(GO:0006808) nitrogen utilization(GO:0019740) |
| 0.5 |
5.3 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) |
| 0.5 |
2.6 |
GO:0061737 |
leukotriene signaling pathway(GO:0061737) |
| 0.5 |
10.0 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.5 |
1.5 |
GO:0017186 |
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.5 |
2.1 |
GO:1903722 |
regulation of centriole elongation(GO:1903722) |
| 0.5 |
8.7 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.5 |
1.5 |
GO:0090427 |
activation of meiosis(GO:0090427) |
| 0.5 |
3.0 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.5 |
4.0 |
GO:0038195 |
urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.5 |
1.0 |
GO:0071156 |
regulation of cell cycle arrest(GO:0071156) |
| 0.5 |
2.5 |
GO:0060455 |
negative regulation of gastric acid secretion(GO:0060455) |
| 0.5 |
10.5 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.5 |
1.5 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.5 |
3.5 |
GO:0060480 |
lung goblet cell differentiation(GO:0060480) |
| 0.5 |
3.5 |
GO:1901569 |
leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.5 |
5.0 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.5 |
6.5 |
GO:0035826 |
rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.5 |
9.9 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.5 |
1.5 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.5 |
4.5 |
GO:0046874 |
quinolinate metabolic process(GO:0046874) |
| 0.5 |
1.5 |
GO:0021569 |
rhombomere 3 development(GO:0021569) |
| 0.5 |
1.5 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.5 |
2.4 |
GO:0015688 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.5 |
1.5 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.5 |
1.5 |
GO:1902824 |
positive regulation of late endosome to lysosome transport(GO:1902824) |
| 0.5 |
1.0 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
| 0.5 |
0.5 |
GO:0072003 |
kidney rudiment formation(GO:0072003) |
| 0.5 |
2.4 |
GO:0034224 |
cellular response to zinc ion starvation(GO:0034224) |
| 0.5 |
1.9 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.5 |
3.4 |
GO:0002447 |
eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
| 0.5 |
2.9 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.5 |
2.4 |
GO:0090341 |
negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 0.5 |
1.4 |
GO:0071629 |
cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 0.5 |
8.1 |
GO:0055089 |
fatty acid homeostasis(GO:0055089) |
| 0.5 |
2.4 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.5 |
1.4 |
GO:0002416 |
IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.5 |
3.8 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.5 |
4.7 |
GO:0000821 |
regulation of arginine metabolic process(GO:0000821) |
| 0.5 |
0.5 |
GO:0035106 |
operant conditioning(GO:0035106) |
| 0.5 |
1.4 |
GO:0003050 |
regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.5 |
1.4 |
GO:0015993 |
molecular hydrogen transport(GO:0015993) |
| 0.5 |
7.0 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.5 |
0.5 |
GO:0038066 |
p38MAPK cascade(GO:0038066) |
| 0.5 |
0.9 |
GO:0048806 |
genitalia development(GO:0048806) |
| 0.5 |
2.7 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.5 |
2.3 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 0.5 |
0.9 |
GO:0003285 |
septum secundum development(GO:0003285) |
| 0.5 |
1.4 |
GO:0052553 |
induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.5 |
0.5 |
GO:0060730 |
regulation of intestinal epithelial structure maintenance(GO:0060730) |
| 0.5 |
0.9 |
GO:0072244 |
metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.4 |
1.3 |
GO:0021919 |
BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 0.4 |
0.4 |
GO:2000382 |
positive regulation of mesoderm development(GO:2000382) |
| 0.4 |
1.3 |
GO:0035754 |
B cell chemotaxis(GO:0035754) |
| 0.4 |
3.1 |
GO:0061031 |
endodermal digestive tract morphogenesis(GO:0061031) |
| 0.4 |
8.0 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.4 |
1.3 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 0.4 |
2.2 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.4 |
2.2 |
GO:0007571 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.4 |
0.4 |
GO:0060535 |
trachea cartilage morphogenesis(GO:0060535) |
| 0.4 |
0.4 |
GO:1904862 |
inhibitory synapse assembly(GO:1904862) |
| 0.4 |
0.9 |
GO:0035054 |
embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 0.4 |
0.4 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.4 |
3.9 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.4 |
2.2 |
GO:0014050 |
negative regulation of glutamate secretion(GO:0014050) |
| 0.4 |
1.7 |
GO:0009236 |
cobalamin biosynthetic process(GO:0009236) |
| 0.4 |
6.0 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.4 |
3.4 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.4 |
10.3 |
GO:1990001 |
inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.4 |
0.4 |
GO:0015813 |
acidic amino acid transport(GO:0015800) L-glutamate transport(GO:0015813) |
| 0.4 |
2.9 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.4 |
0.4 |
GO:0045617 |
negative regulation of epidermal cell differentiation(GO:0045605) negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.4 |
2.1 |
GO:0098502 |
DNA dephosphorylation(GO:0098502) |
| 0.4 |
2.1 |
GO:0001676 |
long-chain fatty acid metabolic process(GO:0001676) |
| 0.4 |
0.8 |
GO:0097187 |
dentinogenesis(GO:0097187) |
| 0.4 |
1.6 |
GO:0002143 |
tRNA wobble position uridine thiolation(GO:0002143) |
| 0.4 |
3.7 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.4 |
2.9 |
GO:0060356 |
leucine import(GO:0060356) |
| 0.4 |
4.9 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.4 |
3.6 |
GO:0006068 |
ethanol catabolic process(GO:0006068) |
| 0.4 |
3.6 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.4 |
2.0 |
GO:0018057 |
peptidyl-lysine oxidation(GO:0018057) |
| 0.4 |
0.4 |
GO:0051125 |
regulation of actin nucleation(GO:0051125) |
| 0.4 |
1.2 |
GO:1902463 |
protein localization to cell leading edge(GO:1902463) |
| 0.4 |
2.4 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.4 |
1.6 |
GO:0048691 |
modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 0.4 |
0.8 |
GO:0033684 |
regulation of luteinizing hormone secretion(GO:0033684) positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.4 |
8.7 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.4 |
2.8 |
GO:0099525 |
presynaptic dense core granule exocytosis(GO:0099525) |
| 0.4 |
0.8 |
GO:0070945 |
neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
| 0.4 |
1.6 |
GO:0036034 |
mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.4 |
1.6 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.4 |
0.8 |
GO:0019853 |
L-ascorbic acid biosynthetic process(GO:0019853) |
| 0.4 |
4.7 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.4 |
2.0 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.4 |
1.6 |
GO:0060474 |
positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 0.4 |
1.9 |
GO:2000359 |
regulation of binding of sperm to zona pellucida(GO:2000359) |
| 0.4 |
3.5 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
| 0.4 |
7.7 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.4 |
1.9 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 0.4 |
0.8 |
GO:2001214 |
positive regulation of vasculogenesis(GO:2001214) |
| 0.4 |
1.2 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.4 |
0.8 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.4 |
2.3 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.4 |
1.9 |
GO:0006203 |
dGTP catabolic process(GO:0006203) |
| 0.4 |
4.1 |
GO:0098795 |
mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.4 |
2.6 |
GO:0044878 |
mitotic cytokinesis checkpoint(GO:0044878) |
| 0.4 |
0.4 |
GO:0060129 |
thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
| 0.4 |
1.9 |
GO:0034154 |
toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.4 |
4.1 |
GO:0046322 |
negative regulation of fatty acid oxidation(GO:0046322) |
| 0.4 |
1.5 |
GO:0098968 |
neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.4 |
0.7 |
GO:0043388 |
positive regulation of DNA binding(GO:0043388) |
| 0.4 |
2.2 |
GO:0010536 |
positive regulation of activation of Janus kinase activity(GO:0010536) |
| 0.4 |
1.5 |
GO:0002501 |
peptide antigen assembly with MHC protein complex(GO:0002501) peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 0.4 |
3.3 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.4 |
0.4 |
GO:2000313 |
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 0.4 |
0.7 |
GO:0003192 |
mitral valve formation(GO:0003192) |
| 0.4 |
1.1 |
GO:0010749 |
regulation of nitric oxide mediated signal transduction(GO:0010749) negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.4 |
4.4 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.4 |
28.4 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.4 |
1.1 |
GO:0042377 |
menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 0.4 |
1.4 |
GO:0006570 |
tyrosine metabolic process(GO:0006570) |
| 0.4 |
0.4 |
GO:0002590 |
regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.4 |
15.4 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.4 |
4.3 |
GO:0050884 |
neuromuscular process controlling posture(GO:0050884) |
| 0.4 |
1.4 |
GO:1903939 |
regulation of TORC2 signaling(GO:1903939) |
| 0.4 |
2.5 |
GO:0030450 |
regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
| 0.4 |
0.7 |
GO:0034445 |
regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.4 |
0.7 |
GO:0043144 |
snoRNA processing(GO:0043144) |
| 0.4 |
0.4 |
GO:1903800 |
positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.4 |
0.7 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) sodium ion homeostasis(GO:0055078) |
| 0.4 |
1.1 |
GO:0006147 |
guanine catabolic process(GO:0006147) |
| 0.3 |
1.7 |
GO:0032425 |
positive regulation of mismatch repair(GO:0032425) |
| 0.3 |
1.4 |
GO:0033132 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.3 |
2.1 |
GO:0009111 |
vitamin catabolic process(GO:0009111) |
| 0.3 |
0.7 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.3 |
1.0 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.3 |
1.4 |
GO:1902723 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.3 |
1.3 |
GO:0050928 |
negative regulation of positive chemotaxis(GO:0050928) |
| 0.3 |
1.7 |
GO:0038169 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.3 |
1.3 |
GO:0001757 |
somite specification(GO:0001757) |
| 0.3 |
0.3 |
GO:0060928 |
atrioventricular node development(GO:0003162) cardiac septum cell differentiation(GO:0003292) atrioventricular node cell differentiation(GO:0060922) atrioventricular node cell development(GO:0060928) |
| 0.3 |
0.7 |
GO:1902110 |
positive regulation of mitochondrial membrane permeability(GO:0035794) positive regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902110) mitochondrial outer membrane permeabilization involved in programmed cell death(GO:1902686) |
| 0.3 |
0.7 |
GO:0016999 |
antibiotic metabolic process(GO:0016999) |
| 0.3 |
0.3 |
GO:0009912 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.3 |
2.0 |
GO:0035407 |
histone H3-T11 phosphorylation(GO:0035407) |
| 0.3 |
1.3 |
GO:0051552 |
flavone metabolic process(GO:0051552) |
| 0.3 |
1.0 |
GO:0042137 |
sequestering of neurotransmitter(GO:0042137) |
| 0.3 |
1.0 |
GO:0046603 |
negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.3 |
1.6 |
GO:0090261 |
positive regulation of inclusion body assembly(GO:0090261) |
| 0.3 |
1.6 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.3 |
2.3 |
GO:0014718 |
positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
| 0.3 |
4.5 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.3 |
1.0 |
GO:0031548 |
regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.3 |
1.0 |
GO:0038178 |
complement component C5a signaling pathway(GO:0038178) |
| 0.3 |
18.7 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.3 |
0.6 |
GO:0090076 |
relaxation of skeletal muscle(GO:0090076) |
| 0.3 |
0.6 |
GO:0019064 |
fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.3 |
0.9 |
GO:0042450 |
arginine biosynthetic process via ornithine(GO:0042450) |
| 0.3 |
7.8 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.3 |
2.2 |
GO:0000432 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.3 |
2.2 |
GO:0060332 |
positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.3 |
0.9 |
GO:0070427 |
nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 0.3 |
1.6 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.3 |
1.9 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.3 |
1.2 |
GO:0090214 |
spongiotrophoblast layer developmental growth(GO:0090214) |
| 0.3 |
0.3 |
GO:0051873 |
disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
| 0.3 |
0.3 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.3 |
0.9 |
GO:0015842 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) phytoalexin metabolic process(GO:0052314) |
| 0.3 |
3.7 |
GO:1904714 |
regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.3 |
1.2 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.3 |
1.5 |
GO:0010807 |
regulation of synaptic vesicle priming(GO:0010807) |
| 0.3 |
0.3 |
GO:0035418 |
protein localization to synapse(GO:0035418) |
| 0.3 |
0.3 |
GO:1904180 |
negative regulation of membrane depolarization(GO:1904180) |
| 0.3 |
1.5 |
GO:2000503 |
regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.3 |
3.9 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.3 |
1.2 |
GO:0048200 |
COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.3 |
0.6 |
GO:1904378 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.3 |
0.9 |
GO:0090190 |
positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
| 0.3 |
3.3 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.3 |
0.9 |
GO:1903659 |
regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.3 |
0.9 |
GO:0000394 |
RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
| 0.3 |
1.5 |
GO:0036017 |
response to erythropoietin(GO:0036017) cellular response to erythropoietin(GO:0036018) |
| 0.3 |
1.2 |
GO:2001301 |
lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 0.3 |
1.2 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.3 |
3.7 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.3 |
1.1 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.3 |
0.3 |
GO:1900222 |
negative regulation of beta-amyloid clearance(GO:1900222) |
| 0.3 |
2.3 |
GO:0035610 |
protein side chain deglutamylation(GO:0035610) |
| 0.3 |
0.3 |
GO:0033197 |
response to vitamin E(GO:0033197) |
| 0.3 |
1.1 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.3 |
1.1 |
GO:1903566 |
positive regulation of protein localization to cilium(GO:1903566) |
| 0.3 |
1.4 |
GO:0060395 |
SMAD protein signal transduction(GO:0060395) |
| 0.3 |
0.8 |
GO:0001994 |
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.3 |
3.3 |
GO:0035751 |
regulation of lysosomal lumen pH(GO:0035751) |
| 0.3 |
1.1 |
GO:0060032 |
notochord regression(GO:0060032) |
| 0.3 |
2.8 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.3 |
0.3 |
GO:0071907 |
determination of digestive tract left/right asymmetry(GO:0071907) |
| 0.3 |
1.6 |
GO:0071104 |
response to interleukin-9(GO:0071104) |
| 0.3 |
0.8 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.3 |
2.5 |
GO:0031087 |
deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.3 |
0.8 |
GO:0070407 |
oxidation-dependent protein catabolic process(GO:0070407) |
| 0.3 |
2.7 |
GO:0046485 |
ether lipid metabolic process(GO:0046485) |
| 0.3 |
0.3 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.3 |
0.8 |
GO:0060061 |
Spemann organizer formation(GO:0060061) |
| 0.3 |
0.3 |
GO:0043366 |
beta selection(GO:0043366) |
| 0.3 |
1.1 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.3 |
0.8 |
GO:0015819 |
lysine transport(GO:0015819) L-lysine transport(GO:1902022) |
| 0.3 |
1.9 |
GO:0021940 |
positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
| 0.3 |
1.1 |
GO:1904044 |
response to aldosterone(GO:1904044) |
| 0.3 |
1.1 |
GO:0006550 |
isoleucine catabolic process(GO:0006550) |
| 0.3 |
2.1 |
GO:1902947 |
regulation of tau-protein kinase activity(GO:1902947) |
| 0.3 |
0.3 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.3 |
3.4 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.3 |
2.1 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.3 |
3.9 |
GO:0006228 |
UTP biosynthetic process(GO:0006228) |
| 0.3 |
1.0 |
GO:0046967 |
cytosol to ER transport(GO:0046967) |
| 0.3 |
0.3 |
GO:0060965 |
negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) negative regulation of gene silencing(GO:0060969) |
| 0.3 |
0.5 |
GO:0006577 |
amino-acid betaine metabolic process(GO:0006577) |
| 0.3 |
0.8 |
GO:0021526 |
medial motor column neuron differentiation(GO:0021526) |
| 0.3 |
7.3 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.3 |
0.3 |
GO:0071623 |
negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 0.3 |
0.8 |
GO:0021966 |
corticospinal neuron axon guidance(GO:0021966) |
| 0.3 |
1.8 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.3 |
0.3 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.3 |
0.8 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 0.3 |
0.8 |
GO:0072573 |
regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of CD40 signaling pathway(GO:2000349) |
| 0.3 |
7.2 |
GO:0072378 |
blood coagulation, fibrin clot formation(GO:0072378) |
| 0.3 |
1.8 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.3 |
10.2 |
GO:0050427 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.3 |
1.8 |
GO:2000809 |
positive regulation of synaptic vesicle clustering(GO:2000809) |
| 0.3 |
1.0 |
GO:0005997 |
xylulose metabolic process(GO:0005997) |
| 0.3 |
0.8 |
GO:1901873 |
regulation of post-translational protein modification(GO:1901873) |
| 0.3 |
0.8 |
GO:0061394 |
regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.3 |
0.3 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.2 |
0.7 |
GO:0006367 |
transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.2 |
0.7 |
GO:0070234 |
positive regulation of T cell apoptotic process(GO:0070234) |
| 0.2 |
1.2 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.2 |
3.0 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.2 |
0.7 |
GO:2000563 |
positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.2 |
0.2 |
GO:0032461 |
positive regulation of protein oligomerization(GO:0032461) |
| 0.2 |
0.7 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.2 |
1.0 |
GO:0019400 |
alditol metabolic process(GO:0019400) |
| 0.2 |
0.5 |
GO:0070857 |
regulation of bile acid biosynthetic process(GO:0070857) |
| 0.2 |
2.7 |
GO:0034127 |
regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034127) negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
| 0.2 |
2.9 |
GO:0003096 |
renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.2 |
1.7 |
GO:0019557 |
histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.2 |
1.9 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.2 |
0.7 |
GO:1900920 |
regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
| 0.2 |
3.6 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.2 |
1.0 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 0.2 |
3.6 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.2 |
1.4 |
GO:0030538 |
embryonic genitalia morphogenesis(GO:0030538) |
| 0.2 |
0.2 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 0.2 |
1.2 |
GO:0044332 |
Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
| 0.2 |
1.9 |
GO:0035456 |
response to interferon-beta(GO:0035456) |
| 0.2 |
0.5 |
GO:0060842 |
arterial endothelial cell differentiation(GO:0060842) |
| 0.2 |
0.7 |
GO:0060033 |
anatomical structure regression(GO:0060033) |
| 0.2 |
0.5 |
GO:0071847 |
TNFSF11-mediated signaling pathway(GO:0071847) negative regulation of bone development(GO:1903011) |
| 0.2 |
0.2 |
GO:0043651 |
linoleic acid metabolic process(GO:0043651) |
| 0.2 |
1.9 |
GO:0032308 |
regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) |
| 0.2 |
4.0 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.2 |
0.5 |
GO:1990845 |
adaptive thermogenesis(GO:1990845) |
| 0.2 |
2.3 |
GO:0090037 |
positive regulation of protein kinase C signaling(GO:0090037) |
| 0.2 |
7.4 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.2 |
0.7 |
GO:1901079 |
positive regulation of relaxation of muscle(GO:1901079) |
| 0.2 |
4.6 |
GO:0090023 |
positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.2 |
1.2 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.2 |
2.8 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.2 |
1.6 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.2 |
0.7 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 0.2 |
0.7 |
GO:0032924 |
activin receptor signaling pathway(GO:0032924) |
| 0.2 |
1.4 |
GO:0090131 |
mesenchyme migration(GO:0090131) |
| 0.2 |
1.8 |
GO:0009753 |
response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.2 |
0.7 |
GO:0071922 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.2 |
2.0 |
GO:0003352 |
regulation of cilium movement(GO:0003352) |
| 0.2 |
0.2 |
GO:0035378 |
carbon dioxide transmembrane transport(GO:0035378) |
| 0.2 |
0.9 |
GO:0030241 |
skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.2 |
0.9 |
GO:0031296 |
B cell costimulation(GO:0031296) |
| 0.2 |
0.9 |
GO:1903412 |
response to bile acid(GO:1903412) |
| 0.2 |
0.2 |
GO:0098907 |
regulation of SA node cell action potential(GO:0098907) |
| 0.2 |
4.5 |
GO:1901642 |
nucleoside transmembrane transport(GO:1901642) |
| 0.2 |
4.9 |
GO:0006855 |
drug transmembrane transport(GO:0006855) |
| 0.2 |
0.2 |
GO:0071469 |
cellular response to alkaline pH(GO:0071469) |
| 0.2 |
8.0 |
GO:0030207 |
chondroitin sulfate catabolic process(GO:0030207) |
| 0.2 |
1.8 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.2 |
0.2 |
GO:0046356 |
acetyl-CoA catabolic process(GO:0046356) |
| 0.2 |
2.0 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.2 |
2.0 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.2 |
3.1 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.2 |
0.4 |
GO:0042668 |
auditory receptor cell fate determination(GO:0042668) |
| 0.2 |
0.4 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 0.2 |
5.9 |
GO:0015988 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) |
| 0.2 |
0.4 |
GO:0046968 |
peptide antigen transport(GO:0046968) |
| 0.2 |
0.2 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.2 |
2.4 |
GO:0048711 |
positive regulation of astrocyte differentiation(GO:0048711) |
| 0.2 |
1.5 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.2 |
0.4 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.2 |
0.2 |
GO:2000854 |
positive regulation of corticosterone secretion(GO:2000854) |
| 0.2 |
0.9 |
GO:0099640 |
axo-dendritic protein transport(GO:0099640) |
| 0.2 |
0.6 |
GO:0045726 |
positive regulation of integrin biosynthetic process(GO:0045726) |
| 0.2 |
1.5 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.2 |
0.2 |
GO:0006311 |
meiotic gene conversion(GO:0006311) |
| 0.2 |
0.6 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.2 |
0.4 |
GO:1990051 |
activation of protein kinase C activity(GO:1990051) |
| 0.2 |
0.8 |
GO:0009138 |
pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
| 0.2 |
1.5 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.2 |
0.2 |
GO:0010701 |
positive regulation of norepinephrine secretion(GO:0010701) |
| 0.2 |
1.3 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.2 |
7.5 |
GO:0070286 |
axonemal dynein complex assembly(GO:0070286) |
| 0.2 |
0.4 |
GO:0002087 |
regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
| 0.2 |
1.0 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.2 |
1.2 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.2 |
1.0 |
GO:0046689 |
response to mercury ion(GO:0046689) |
| 0.2 |
1.4 |
GO:0035897 |
proteolysis in other organism(GO:0035897) |
| 0.2 |
0.8 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.2 |
1.0 |
GO:0019303 |
D-ribose catabolic process(GO:0019303) |
| 0.2 |
0.4 |
GO:0043652 |
engulfment of apoptotic cell(GO:0043652) |
| 0.2 |
0.2 |
GO:1902523 |
positive regulation of protein K63-linked ubiquitination(GO:1902523) |
| 0.2 |
0.2 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 0.2 |
0.8 |
GO:0006480 |
N-terminal protein amino acid methylation(GO:0006480) |
| 0.2 |
0.8 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.2 |
0.6 |
GO:1902283 |
negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.2 |
0.6 |
GO:0046041 |
ITP metabolic process(GO:0046041) |
| 0.2 |
1.2 |
GO:0060523 |
prostate epithelial cord elongation(GO:0060523) |
| 0.2 |
2.8 |
GO:1901678 |
heme transport(GO:0015886) iron coordination entity transport(GO:1901678) |
| 0.2 |
0.6 |
GO:0033058 |
directional locomotion(GO:0033058) |
| 0.2 |
1.8 |
GO:0042984 |
amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.2 |
0.8 |
GO:0070845 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.2 |
0.8 |
GO:0086097 |
phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.2 |
0.8 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 0.2 |
2.4 |
GO:0006702 |
androgen biosynthetic process(GO:0006702) |
| 0.2 |
2.4 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.2 |
0.6 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.2 |
4.7 |
GO:1901685 |
glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.2 |
1.4 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.2 |
3.1 |
GO:0035641 |
locomotory exploration behavior(GO:0035641) |
| 0.2 |
0.8 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 0.2 |
3.7 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.2 |
0.8 |
GO:0032690 |
negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 0.2 |
0.4 |
GO:0030886 |
negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 0.2 |
21.5 |
GO:0071357 |
type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.2 |
0.2 |
GO:0097212 |
lysosomal membrane organization(GO:0097212) |
| 0.2 |
0.8 |
GO:0060331 |
negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
| 0.2 |
1.9 |
GO:0007202 |
activation of phospholipase C activity(GO:0007202) |
| 0.2 |
1.2 |
GO:0030421 |
defecation(GO:0030421) |
| 0.2 |
0.2 |
GO:0060573 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.2 |
0.6 |
GO:1904428 |
negative regulation of tubulin deacetylation(GO:1904428) |
| 0.2 |
0.8 |
GO:0019417 |
sulfur oxidation(GO:0019417) |
| 0.2 |
0.8 |
GO:0035803 |
egg coat formation(GO:0035803) |
| 0.2 |
2.7 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.2 |
0.4 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.2 |
1.3 |
GO:0008218 |
bioluminescence(GO:0008218) |
| 0.2 |
2.3 |
GO:0010988 |
regulation of low-density lipoprotein particle clearance(GO:0010988) |
| 0.2 |
6.0 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 0.2 |
21.9 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.2 |
0.8 |
GO:0033499 |
galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.2 |
0.9 |
GO:0000720 |
pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.2 |
2.6 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.2 |
0.4 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.2 |
0.2 |
GO:1900449 |
regulation of glutamate receptor signaling pathway(GO:1900449) |
| 0.2 |
0.4 |
GO:1901253 |
negative regulation of intracellular transport of viral material(GO:1901253) |
| 0.2 |
0.7 |
GO:1902361 |
mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.2 |
0.6 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.2 |
1.7 |
GO:0006216 |
cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.2 |
3.1 |
GO:0048557 |
embryonic digestive tract morphogenesis(GO:0048557) |
| 0.2 |
0.2 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.2 |
0.6 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.2 |
1.1 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.2 |
1.8 |
GO:0006582 |
melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
| 0.2 |
0.5 |
GO:1902993 |
positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
| 0.2 |
6.9 |
GO:1904659 |
hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.2 |
1.3 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.2 |
1.1 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.2 |
1.8 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.2 |
1.8 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.2 |
0.2 |
GO:0002924 |
negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.2 |
1.8 |
GO:0002675 |
positive regulation of acute inflammatory response(GO:0002675) |
| 0.2 |
0.4 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 0.2 |
0.4 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.2 |
0.5 |
GO:0009822 |
alkaloid catabolic process(GO:0009822) |
| 0.2 |
0.5 |
GO:0072616 |
interleukin-18 secretion(GO:0072616) |
| 0.2 |
1.1 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.2 |
1.1 |
GO:2000169 |
regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
| 0.2 |
0.2 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.2 |
1.4 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.2 |
0.9 |
GO:0071409 |
cellular response to cycloheximide(GO:0071409) |
| 0.2 |
0.4 |
GO:0019442 |
tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 0.2 |
0.5 |
GO:0009443 |
pyridoxal 5'-phosphate salvage(GO:0009443) |
| 0.2 |
0.4 |
GO:0010513 |
positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
| 0.2 |
1.1 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.2 |
0.5 |
GO:0044130 |
negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.2 |
1.1 |
GO:0043128 |
regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.2 |
1.6 |
GO:0035912 |
dorsal aorta morphogenesis(GO:0035912) |
| 0.2 |
0.7 |
GO:1990535 |
neuron projection maintenance(GO:1990535) |
| 0.2 |
2.5 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.2 |
0.2 |
GO:0002399 |
MHC class II protein complex assembly(GO:0002399) |
| 0.2 |
0.5 |
GO:0002755 |
MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.2 |
0.5 |
GO:0001829 |
trophectodermal cell differentiation(GO:0001829) |
| 0.2 |
2.8 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.2 |
2.3 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.2 |
0.7 |
GO:0045872 |
positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.2 |
1.0 |
GO:0010872 |
regulation of cholesterol esterification(GO:0010872) |
| 0.2 |
0.9 |
GO:2001183 |
negative regulation of interleukin-10 secretion(GO:2001180) negative regulation of interleukin-12 secretion(GO:2001183) |
| 0.2 |
0.2 |
GO:0000820 |
regulation of glutamine family amino acid metabolic process(GO:0000820) |
| 0.2 |
0.5 |
GO:0072108 |
positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
| 0.2 |
0.5 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.2 |
1.9 |
GO:0036503 |
ERAD pathway(GO:0036503) |
| 0.2 |
0.5 |
GO:0007343 |
egg activation(GO:0007343) female pronucleus assembly(GO:0035038) |
| 0.2 |
0.8 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 0.2 |
0.5 |
GO:1902938 |
regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 0.2 |
1.0 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.2 |
1.3 |
GO:0044211 |
CTP salvage(GO:0044211) |
| 0.2 |
0.7 |
GO:0045919 |
positive regulation of cytolysis(GO:0045919) |
| 0.2 |
1.2 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.2 |
0.8 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.2 |
0.7 |
GO:1905224 |
clathrin-coated pit assembly(GO:1905224) |
| 0.2 |
0.7 |
GO:1903949 |
positive regulation of actin filament-based movement(GO:1903116) positive regulation of atrial cardiac muscle cell action potential(GO:1903949) |
| 0.2 |
0.5 |
GO:1990697 |
protein depalmitoleylation(GO:1990697) |
| 0.2 |
0.3 |
GO:0034310 |
primary alcohol catabolic process(GO:0034310) |
| 0.2 |
1.5 |
GO:0002291 |
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.2 |
5.1 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.2 |
3.2 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.2 |
2.9 |
GO:0050995 |
negative regulation of lipid catabolic process(GO:0050995) |
| 0.2 |
0.5 |
GO:0038033 |
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.2 |
0.3 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.2 |
0.2 |
GO:0044027 |
UDP-glucose catabolic process(GO:0006258) hypermethylation of CpG island(GO:0044027) |
| 0.2 |
0.2 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.2 |
1.3 |
GO:0045040 |
protein import into mitochondrial outer membrane(GO:0045040) |
| 0.2 |
0.2 |
GO:0030185 |
nitric oxide transport(GO:0030185) |
| 0.2 |
1.0 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.2 |
0.3 |
GO:0061034 |
olfactory bulb mitral cell layer development(GO:0061034) |
| 0.2 |
0.2 |
GO:0046321 |
positive regulation of fatty acid oxidation(GO:0046321) |
| 0.2 |
2.7 |
GO:0060044 |
negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.2 |
0.6 |
GO:0061525 |
hindgut development(GO:0061525) |
| 0.2 |
1.4 |
GO:0045343 |
MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 0.2 |
0.5 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.2 |
0.3 |
GO:1990167 |
protein K27-linked deubiquitination(GO:1990167) |
| 0.2 |
0.9 |
GO:0010918 |
positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.2 |
3.6 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.2 |
0.9 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.2 |
2.8 |
GO:0019371 |
cyclooxygenase pathway(GO:0019371) |
| 0.2 |
1.4 |
GO:0043152 |
induction of bacterial agglutination(GO:0043152) |
| 0.2 |
3.3 |
GO:1902884 |
positive regulation of response to oxidative stress(GO:1902884) |
| 0.2 |
1.6 |
GO:0002943 |
tRNA dihydrouridine synthesis(GO:0002943) |
| 0.2 |
0.3 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.2 |
0.5 |
GO:0010259 |
multicellular organism aging(GO:0010259) |
| 0.2 |
1.1 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.2 |
0.5 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.2 |
2.9 |
GO:0050655 |
dermatan sulfate proteoglycan metabolic process(GO:0050655) |
| 0.2 |
0.6 |
GO:0045208 |
MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
| 0.2 |
1.5 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.2 |
0.6 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.2 |
18.8 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.2 |
0.8 |
GO:0010819 |
regulation of T cell chemotaxis(GO:0010819) |
| 0.2 |
0.2 |
GO:0048262 |
determination of dorsal/ventral asymmetry(GO:0048262) |
| 0.2 |
0.2 |
GO:2001015 |
negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.2 |
0.9 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.2 |
0.8 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.2 |
1.2 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.2 |
0.5 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.2 |
2.6 |
GO:0015865 |
purine nucleotide transport(GO:0015865) |
| 0.2 |
0.5 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.1 |
0.7 |
GO:0045337 |
geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
| 0.1 |
0.9 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.1 |
0.6 |
GO:0098905 |
regulation of bundle of His cell action potential(GO:0098905) |
| 0.1 |
0.3 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.1 |
1.0 |
GO:0071391 |
cellular response to estrogen stimulus(GO:0071391) |
| 0.1 |
0.6 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.1 |
0.1 |
GO:0071351 |
interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
| 0.1 |
1.0 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.1 |
3.1 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.1 |
0.7 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.1 |
0.1 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.1 |
0.7 |
GO:0071934 |
thiamine transmembrane transport(GO:0071934) |
| 0.1 |
0.7 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.1 |
3.5 |
GO:1901663 |
ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.1 |
1.2 |
GO:0021527 |
spinal cord association neuron differentiation(GO:0021527) |
| 0.1 |
1.0 |
GO:0006658 |
phosphatidylserine metabolic process(GO:0006658) phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.1 |
1.0 |
GO:0036152 |
phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.1 |
0.3 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 0.1 |
19.9 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 |
0.3 |
GO:0055073 |
cadmium ion homeostasis(GO:0055073) |
| 0.1 |
1.0 |
GO:0006021 |
inositol biosynthetic process(GO:0006021) |
| 0.1 |
7.4 |
GO:0006735 |
NADH regeneration(GO:0006735) glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.1 |
0.6 |
GO:1902869 |
regulation of amacrine cell differentiation(GO:1902869) |
| 0.1 |
0.6 |
GO:1905244 |
regulation of modification of synaptic structure(GO:1905244) |
| 0.1 |
0.8 |
GO:0060297 |
regulation of sarcomere organization(GO:0060297) |
| 0.1 |
7.4 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 |
0.1 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.1 |
0.8 |
GO:0061113 |
pancreas morphogenesis(GO:0061113) |
| 0.1 |
0.3 |
GO:0051891 |
endodermal cell fate determination(GO:0007493) positive regulation of cardioblast differentiation(GO:0051891) |
| 0.1 |
0.7 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.1 |
0.4 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.1 |
0.6 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.1 |
0.7 |
GO:0060606 |
neural tube closure(GO:0001843) tube closure(GO:0060606) |
| 0.1 |
0.4 |
GO:0051586 |
positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.1 |
0.1 |
GO:0045416 |
positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
| 0.1 |
0.3 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
| 0.1 |
0.4 |
GO:0043328 |
protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.1 |
0.3 |
GO:0052501 |
induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) |
| 0.1 |
0.4 |
GO:0070091 |
glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 0.1 |
0.4 |
GO:0034163 |
regulation of toll-like receptor 9 signaling pathway(GO:0034163) negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.1 |
0.4 |
GO:0044209 |
AMP salvage(GO:0044209) |
| 0.1 |
0.8 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.1 |
0.4 |
GO:1903781 |
positive regulation of cardiac conduction(GO:1903781) |
| 0.1 |
0.8 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 0.1 |
0.5 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 |
0.5 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) |
| 0.1 |
1.8 |
GO:0051938 |
L-glutamate import(GO:0051938) |
| 0.1 |
0.4 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
| 0.1 |
0.1 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.1 |
0.8 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.1 |
1.3 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.1 |
0.1 |
GO:0007468 |
regulation of rhodopsin gene expression(GO:0007468) |
| 0.1 |
0.4 |
GO:0042727 |
flavin-containing compound biosynthetic process(GO:0042727) |
| 0.1 |
0.4 |
GO:0048213 |
Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.1 |
0.8 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.1 |
2.0 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.1 |
1.1 |
GO:0097577 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.1 |
1.1 |
GO:0032226 |
positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
| 0.1 |
0.1 |
GO:0045590 |
negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.1 |
0.7 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 |
0.5 |
GO:0010002 |
cardioblast differentiation(GO:0010002) |
| 0.1 |
0.5 |
GO:0061107 |
seminal vesicle development(GO:0061107) |
| 0.1 |
0.4 |
GO:1903348 |
positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.1 |
0.7 |
GO:1901379 |
regulation of potassium ion transmembrane transport(GO:1901379) |
| 0.1 |
0.4 |
GO:0061589 |
calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.1 |
2.3 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.1 |
0.5 |
GO:0071502 |
cellular response to temperature stimulus(GO:0071502) |
| 0.1 |
0.9 |
GO:0090129 |
positive regulation of synapse maturation(GO:0090129) |
| 0.1 |
0.6 |
GO:0014057 |
positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
| 0.1 |
1.2 |
GO:0060856 |
establishment of blood-brain barrier(GO:0060856) |
| 0.1 |
0.3 |
GO:0071379 |
cellular response to prostaglandin stimulus(GO:0071379) |
| 0.1 |
0.3 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.1 |
1.0 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 |
1.9 |
GO:0035878 |
nail development(GO:0035878) |
| 0.1 |
0.4 |
GO:1902630 |
regulation of membrane hyperpolarization(GO:1902630) |
| 0.1 |
0.6 |
GO:0043932 |
ossification involved in bone remodeling(GO:0043932) |
| 0.1 |
0.4 |
GO:0030187 |
melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.1 |
0.6 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 0.1 |
0.8 |
GO:0036309 |
protein localization to M-band(GO:0036309) |
| 0.1 |
0.4 |
GO:1903697 |
negative regulation of microvillus assembly(GO:1903697) |
| 0.1 |
0.3 |
GO:0051040 |
regulation of calcium-independent cell-cell adhesion(GO:0051040) |
| 0.1 |
0.1 |
GO:0060292 |
long term synaptic depression(GO:0060292) |
| 0.1 |
0.3 |
GO:2000354 |
regulation of ovarian follicle development(GO:2000354) |
| 0.1 |
1.4 |
GO:0060088 |
auditory receptor cell stereocilium organization(GO:0060088) |
| 0.1 |
0.4 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.1 |
1.2 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.1 |
0.4 |
GO:0046709 |
IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 0.1 |
0.1 |
GO:0060971 |
embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.1 |
0.5 |
GO:0090362 |
positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.1 |
0.2 |
GO:0042822 |
pyridoxal phosphate metabolic process(GO:0042822) |
| 0.1 |
0.1 |
GO:0002767 |
immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
| 0.1 |
0.5 |
GO:0042417 |
dopamine metabolic process(GO:0042417) |
| 0.1 |
1.3 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) |
| 0.1 |
0.1 |
GO:0045582 |
positive regulation of T cell differentiation(GO:0045582) |
| 0.1 |
0.5 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 |
1.0 |
GO:0032364 |
oxygen homeostasis(GO:0032364) |
| 0.1 |
0.5 |
GO:0046379 |
extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.1 |
0.4 |
GO:0060823 |
canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
| 0.1 |
4.8 |
GO:0019228 |
neuronal action potential(GO:0019228) |
| 0.1 |
0.2 |
GO:2001033 |
negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
| 0.1 |
1.7 |
GO:0036148 |
phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.1 |
2.4 |
GO:0031640 |
killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.1 |
1.3 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.1 |
2.5 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.1 |
1.2 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.1 |
0.7 |
GO:0070672 |
response to interleukin-15(GO:0070672) |
| 0.1 |
0.1 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.1 |
0.5 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.1 |
0.5 |
GO:1900111 |
positive regulation of histone H3-K9 dimethylation(GO:1900111) |
| 0.1 |
1.6 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.1 |
1.9 |
GO:0021891 |
olfactory bulb interneuron development(GO:0021891) |
| 0.1 |
1.0 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.1 |
1.4 |
GO:0050482 |
arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.1 |
0.3 |
GO:0042269 |
regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
| 0.1 |
0.7 |
GO:0042832 |
defense response to protozoan(GO:0042832) |
| 0.1 |
1.3 |
GO:0036149 |
phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.1 |
0.5 |
GO:1903803 |
glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.1 |
0.7 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.1 |
0.1 |
GO:0033685 |
negative regulation of luteinizing hormone secretion(GO:0033685) |
| 0.1 |
7.1 |
GO:0002448 |
mast cell mediated immunity(GO:0002448) |
| 0.1 |
1.9 |
GO:0071027 |
nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.1 |
1.0 |
GO:0009227 |
nucleotide-sugar catabolic process(GO:0009227) |
| 0.1 |
0.7 |
GO:0002378 |
immunoglobulin biosynthetic process(GO:0002378) |
| 0.1 |
1.3 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.1 |
1.8 |
GO:0046951 |
ketone body biosynthetic process(GO:0046951) |
| 0.1 |
2.0 |
GO:0060972 |
left/right pattern formation(GO:0060972) |
| 0.1 |
0.2 |
GO:0042226 |
interleukin-6 biosynthetic process(GO:0042226) |
| 0.1 |
0.6 |
GO:0033274 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.1 |
1.0 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.1 |
0.6 |
GO:1903307 |
positive regulation of regulated secretory pathway(GO:1903307) |
| 0.1 |
0.8 |
GO:0051023 |
regulation of immunoglobulin secretion(GO:0051023) |
| 0.1 |
0.4 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.1 |
1.0 |
GO:0033141 |
positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.1 |
0.2 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.1 |
1.4 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 |
1.0 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.1 |
0.2 |
GO:0007195 |
adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 0.1 |
14.6 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
| 0.1 |
1.6 |
GO:0046337 |
phosphatidylethanolamine metabolic process(GO:0046337) |
| 0.1 |
1.3 |
GO:0006782 |
protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.1 |
0.4 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.1 |
0.4 |
GO:0032077 |
positive regulation of deoxyribonuclease activity(GO:0032077) |
| 0.1 |
2.5 |
GO:0006734 |
NADH metabolic process(GO:0006734) |
| 0.1 |
0.4 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.1 |
1.0 |
GO:0070560 |
protein secretion by platelet(GO:0070560) |
| 0.1 |
1.2 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.1 |
3.9 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
| 0.1 |
0.3 |
GO:1904781 |
positive regulation of protein localization to centrosome(GO:1904781) |
| 0.1 |
0.3 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.1 |
0.3 |
GO:1903376 |
neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.1 |
0.6 |
GO:1904219 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 |
0.2 |
GO:0002625 |
regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.1 |
0.5 |
GO:0032228 |
regulation of synaptic transmission, GABAergic(GO:0032228) |
| 0.1 |
1.3 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.1 |
0.3 |
GO:0070409 |
carbamoyl phosphate metabolic process(GO:0070408) carbamoyl phosphate biosynthetic process(GO:0070409) response to ammonia(GO:1903717) cellular response to ammonia(GO:1903718) |
| 0.1 |
0.3 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.1 |
2.4 |
GO:0097031 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 |
0.1 |
GO:0006579 |
amino-acid betaine catabolic process(GO:0006579) |
| 0.1 |
0.2 |
GO:2000275 |
regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.1 |
0.3 |
GO:0006655 |
phosphatidylglycerol biosynthetic process(GO:0006655) |
| 0.1 |
0.3 |
GO:0060903 |
positive regulation of meiosis I(GO:0060903) |
| 0.1 |
0.1 |
GO:0061091 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.1 |
0.1 |
GO:0035283 |
central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.1 |
0.8 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.1 |
0.3 |
GO:0098780 |
response to mitochondrial depolarisation(GO:0098780) |
| 0.1 |
1.1 |
GO:0006119 |
oxidative phosphorylation(GO:0006119) |
| 0.1 |
1.2 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.1 |
0.2 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.1 |
0.3 |
GO:0034553 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.1 |
0.2 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.1 |
0.3 |
GO:0032703 |
negative regulation of interleukin-2 production(GO:0032703) |
| 0.1 |
0.1 |
GO:0002664 |
regulation of T cell tolerance induction(GO:0002664) |
| 0.1 |
0.5 |
GO:1903772 |
regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.1 |
1.6 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.1 |
0.3 |
GO:1904586 |
response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) hepatocyte dedifferentiation(GO:1990828) |
| 0.1 |
0.3 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.1 |
0.7 |
GO:1900113 |
negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.1 |
0.2 |
GO:0045423 |
lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
| 0.1 |
0.4 |
GO:0035385 |
Roundabout signaling pathway(GO:0035385) |
| 0.1 |
0.5 |
GO:0052150 |
modulation by symbiont of host apoptotic process(GO:0052150) |
| 0.1 |
1.1 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.1 |
4.6 |
GO:0018279 |
protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.1 |
2.0 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.1 |
0.3 |
GO:0035672 |
oligopeptide transmembrane transport(GO:0035672) |
| 0.1 |
0.1 |
GO:0019081 |
viral translation(GO:0019081) |
| 0.1 |
0.4 |
GO:0050766 |
positive regulation of phagocytosis(GO:0050766) |
| 0.1 |
0.4 |
GO:0033625 |
positive regulation of integrin activation(GO:0033625) |
| 0.1 |
0.2 |
GO:0060298 |
positive regulation of sarcomere organization(GO:0060298) |
| 0.1 |
1.1 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.1 |
0.2 |
GO:0002027 |
regulation of heart rate(GO:0002027) |
| 0.1 |
0.6 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
| 0.1 |
1.5 |
GO:0045023 |
G0 to G1 transition(GO:0045023) |
| 0.1 |
0.3 |
GO:0051001 |
negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.1 |
0.4 |
GO:0048663 |
neuron fate commitment(GO:0048663) |
| 0.1 |
2.0 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.1 |
0.8 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.1 |
1.0 |
GO:0015760 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 |
0.6 |
GO:0045047 |
protein targeting to ER(GO:0045047) |
| 0.1 |
0.8 |
GO:0070525 |
tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
| 0.1 |
0.5 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.1 |
0.1 |
GO:0014717 |
regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
| 0.1 |
1.3 |
GO:0006527 |
arginine catabolic process(GO:0006527) |
| 0.1 |
1.9 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 |
1.5 |
GO:0006828 |
manganese ion transport(GO:0006828) |
| 0.1 |
1.7 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.1 |
1.2 |
GO:0071545 |
inositol phosphate catabolic process(GO:0071545) |
| 0.1 |
0.3 |
GO:1901522 |
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
| 0.1 |
0.2 |
GO:0002018 |
renin-angiotensin regulation of aldosterone production(GO:0002018) |
| 0.1 |
0.4 |
GO:0032377 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.1 |
0.1 |
GO:0001696 |
gastric acid secretion(GO:0001696) |
| 0.1 |
0.4 |
GO:1903859 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.1 |
0.1 |
GO:0070434 |
positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 0.1 |
0.7 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.1 |
0.8 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.1 |
0.1 |
GO:0002825 |
regulation of T-helper 1 type immune response(GO:0002825) positive regulation of T-helper 1 type immune response(GO:0002827) |
| 0.1 |
0.5 |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.1 |
0.4 |
GO:0001554 |
luteolysis(GO:0001554) |
| 0.1 |
0.3 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.1 |
0.9 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 0.1 |
0.3 |
GO:0034344 |
type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.1 |
0.6 |
GO:2000546 |
positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.1 |
0.7 |
GO:0009133 |
nucleoside diphosphate biosynthetic process(GO:0009133) |
| 0.1 |
1.0 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.1 |
0.8 |
GO:0072498 |
embryonic skeletal joint development(GO:0072498) |
| 0.1 |
3.1 |
GO:0097503 |
sialylation(GO:0097503) |
| 0.1 |
0.4 |
GO:0014043 |
negative regulation of neuron maturation(GO:0014043) |
| 0.1 |
0.7 |
GO:2000637 |
positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.1 |
0.3 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.1 |
0.4 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.1 |
0.3 |
GO:2001238 |
positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.1 |
0.3 |
GO:0072236 |
metanephric loop of Henle development(GO:0072236) |
| 0.1 |
0.3 |
GO:1904617 |
regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
| 0.1 |
0.2 |
GO:0050912 |
detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
| 0.1 |
0.2 |
GO:1902221 |
L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.1 |
1.0 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.1 |
0.6 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.1 |
0.1 |
GO:1904798 |
regulation of core promoter binding(GO:1904796) positive regulation of core promoter binding(GO:1904798) |
| 0.1 |
0.3 |
GO:0097021 |
lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.1 |
0.2 |
GO:0021722 |
superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.1 |
0.5 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 |
0.4 |
GO:0010732 |
protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 0.1 |
0.6 |
GO:0060390 |
regulation of SMAD protein import into nucleus(GO:0060390) |
| 0.1 |
0.2 |
GO:1902430 |
negative regulation of beta-amyloid formation(GO:1902430) |
| 0.1 |
1.7 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.1 |
0.3 |
GO:0002074 |
extraocular skeletal muscle development(GO:0002074) |
| 0.1 |
0.6 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.1 |
0.2 |
GO:0042090 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 |
2.9 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.1 |
0.2 |
GO:0006772 |
thiamine metabolic process(GO:0006772) |
| 0.1 |
0.9 |
GO:0010996 |
response to auditory stimulus(GO:0010996) |
| 0.1 |
0.5 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.1 |
0.2 |
GO:0003408 |
optic cup formation involved in camera-type eye development(GO:0003408) |
| 0.1 |
0.5 |
GO:0098758 |
interleukin-8-mediated signaling pathway(GO:0038112) response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 0.1 |
0.2 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 |
0.4 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.1 |
0.2 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.1 |
1.6 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 0.1 |
0.3 |
GO:0035425 |
autocrine signaling(GO:0035425) |
| 0.1 |
0.5 |
GO:0071498 |
cellular response to fluid shear stress(GO:0071498) |
| 0.1 |
5.9 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
| 0.1 |
0.2 |
GO:0008628 |
hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 0.1 |
0.6 |
GO:0003322 |
pancreatic A cell development(GO:0003322) |
| 0.1 |
1.7 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.1 |
0.7 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.1 |
0.2 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.1 |
0.1 |
GO:1902616 |
acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.1 |
0.1 |
GO:0032414 |
positive regulation of ion transmembrane transporter activity(GO:0032414) |
| 0.1 |
2.6 |
GO:0007271 |
synaptic transmission, cholinergic(GO:0007271) |
| 0.1 |
0.4 |
GO:0007341 |
penetration of zona pellucida(GO:0007341) |
| 0.1 |
0.3 |
GO:0021885 |
forebrain cell migration(GO:0021885) |
| 0.1 |
0.2 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.1 |
2.0 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.1 |
0.7 |
GO:0046549 |
retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.1 |
0.4 |
GO:0051581 |
negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.1 |
0.9 |
GO:1900227 |
positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.1 |
0.2 |
GO:0002728 |
negative regulation of natural killer cell cytokine production(GO:0002728) |
| 0.1 |
0.9 |
GO:0051281 |
positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
| 0.1 |
0.1 |
GO:0009261 |
purine ribonucleotide catabolic process(GO:0009154) ribonucleotide catabolic process(GO:0009261) |
| 0.1 |
0.1 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
| 0.1 |
0.8 |
GO:0060334 |
regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.1 |
0.8 |
GO:0003416 |
endochondral bone growth(GO:0003416) |
| 0.1 |
0.2 |
GO:0050760 |
negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.1 |
0.2 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.1 |
1.5 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.1 |
0.5 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.1 |
0.3 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.1 |
0.2 |
GO:1904046 |
negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.1 |
0.3 |
GO:0090394 |
negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.1 |
0.2 |
GO:1902598 |
creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 0.1 |
0.4 |
GO:1901841 |
regulation of high voltage-gated calcium channel activity(GO:1901841) |
| 0.1 |
0.3 |
GO:1900060 |
negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.1 |
0.1 |
GO:0032736 |
positive regulation of interleukin-13 production(GO:0032736) |
| 0.1 |
0.3 |
GO:1904879 |
positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.1 |
0.9 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 0.1 |
0.8 |
GO:0000469 |
cleavage involved in rRNA processing(GO:0000469) |
| 0.1 |
0.3 |
GO:0019732 |
antifungal humoral response(GO:0019732) |
| 0.1 |
0.3 |
GO:0016098 |
monoterpenoid metabolic process(GO:0016098) |
| 0.1 |
0.3 |
GO:0019098 |
reproductive behavior(GO:0019098) maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.1 |
0.1 |
GO:0040018 |
positive regulation of multicellular organism growth(GO:0040018) |
| 0.1 |
0.2 |
GO:0044727 |
DNA demethylation of male pronucleus(GO:0044727) |
| 0.1 |
0.1 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.1 |
0.8 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.1 |
0.5 |
GO:0001881 |
receptor recycling(GO:0001881) |
| 0.1 |
0.6 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.1 |
0.4 |
GO:1900273 |
positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.1 |
0.1 |
GO:0002467 |
germinal center formation(GO:0002467) |
| 0.1 |
0.2 |
GO:1900063 |
regulation of peroxisome organization(GO:1900063) |
| 0.1 |
0.7 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.1 |
0.1 |
GO:0006711 |
estrogen catabolic process(GO:0006711) |
| 0.1 |
0.2 |
GO:0035674 |
tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.1 |
0.1 |
GO:0035065 |
regulation of histone acetylation(GO:0035065) |
| 0.1 |
0.9 |
GO:0048665 |
neuron fate specification(GO:0048665) |
| 0.1 |
1.1 |
GO:1901798 |
positive regulation of signal transduction by p53 class mediator(GO:1901798) |
| 0.1 |
2.4 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.1 |
0.1 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.1 |
2.2 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.1 |
0.4 |
GO:0033085 |
negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
| 0.1 |
0.3 |
GO:1904158 |
axonemal central apparatus assembly(GO:1904158) |
| 0.1 |
0.3 |
GO:1902261 |
positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
| 0.1 |
0.4 |
GO:0044245 |
polysaccharide digestion(GO:0044245) |
| 0.1 |
0.3 |
GO:0043335 |
protein unfolding(GO:0043335) |
| 0.1 |
0.2 |
GO:0043438 |
acetoacetic acid metabolic process(GO:0043438) |
| 0.1 |
0.7 |
GO:0061577 |
calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.1 |
1.7 |
GO:0097502 |
mannosylation(GO:0097502) |
| 0.1 |
0.3 |
GO:0051155 |
positive regulation of striated muscle cell differentiation(GO:0051155) |
| 0.1 |
0.4 |
GO:1902679 |
negative regulation of RNA biosynthetic process(GO:1902679) |
| 0.1 |
0.2 |
GO:0071340 |
skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.1 |
0.6 |
GO:0006707 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 |
0.2 |
GO:0097090 |
presynaptic membrane organization(GO:0097090) |
| 0.1 |
0.1 |
GO:0060748 |
tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 0.1 |
0.8 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.1 |
0.7 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.1 |
4.9 |
GO:0072376 |
protein activation cascade(GO:0072376) |
| 0.1 |
0.9 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.1 |
0.1 |
GO:0002911 |
lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.1 |
0.2 |
GO:0019605 |
butyrate metabolic process(GO:0019605) |
| 0.1 |
0.1 |
GO:0035815 |
positive regulation of renal sodium excretion(GO:0035815) |
| 0.1 |
0.1 |
GO:0006879 |
cellular iron ion homeostasis(GO:0006879) |
| 0.1 |
0.2 |
GO:0015691 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.1 |
0.4 |
GO:0032329 |
L-serine transport(GO:0015825) serine transport(GO:0032329) |
| 0.1 |
0.5 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.1 |
0.7 |
GO:0051350 |
negative regulation of lyase activity(GO:0051350) |
| 0.1 |
2.5 |
GO:0035036 |
sperm-egg recognition(GO:0035036) |
| 0.1 |
1.7 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.1 |
0.6 |
GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
| 0.1 |
0.8 |
GO:0030050 |
vesicle transport along actin filament(GO:0030050) |
| 0.1 |
0.2 |
GO:0072081 |
proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) specification of loop of Henle identity(GO:0072086) |
| 0.1 |
0.8 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.1 |
0.3 |
GO:0031337 |
cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) positive regulation of homocysteine metabolic process(GO:0050668) |
| 0.1 |
0.6 |
GO:0010968 |
regulation of microtubule nucleation(GO:0010968) |
| 0.1 |
0.3 |
GO:1904430 |
negative regulation of t-circle formation(GO:1904430) |
| 0.1 |
0.5 |
GO:0061051 |
positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.1 |
0.8 |
GO:0035690 |
cellular response to drug(GO:0035690) |
| 0.1 |
0.6 |
GO:0048265 |
response to pain(GO:0048265) |
| 0.1 |
0.2 |
GO:0051898 |
negative regulation of protein kinase B signaling(GO:0051898) |
| 0.1 |
0.1 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.1 |
0.3 |
GO:0046958 |
nonassociative learning(GO:0046958) |
| 0.1 |
0.1 |
GO:1901877 |
regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.1 |
0.2 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.1 |
0.1 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 |
0.6 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 |
0.6 |
GO:0016556 |
mRNA modification(GO:0016556) |
| 0.1 |
0.2 |
GO:0002544 |
chronic inflammatory response(GO:0002544) |
| 0.1 |
0.5 |
GO:0010944 |
negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.1 |
0.3 |
GO:1904152 |
regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.1 |
0.7 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.1 |
0.2 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.1 |
0.2 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.1 |
0.3 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.1 |
1.3 |
GO:0035090 |
maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.1 |
0.1 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.1 |
0.2 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.1 |
0.5 |
GO:0034122 |
negative regulation of toll-like receptor signaling pathway(GO:0034122) |
| 0.1 |
0.4 |
GO:0051791 |
medium-chain fatty acid metabolic process(GO:0051791) |
| 0.1 |
0.4 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.1 |
0.5 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 |
0.2 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 |
1.7 |
GO:0022400 |
regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.1 |
0.2 |
GO:1904899 |
regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.1 |
0.1 |
GO:0030647 |
glycoside metabolic process(GO:0016137) aminoglycoside antibiotic metabolic process(GO:0030647) |
| 0.1 |
0.8 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.1 |
2.2 |
GO:0006487 |
protein N-linked glycosylation(GO:0006487) |
| 0.1 |
0.1 |
GO:0042116 |
macrophage activation(GO:0042116) |
| 0.1 |
0.3 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.1 |
0.2 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 |
0.7 |
GO:0048016 |
inositol phosphate-mediated signaling(GO:0048016) |
| 0.1 |
0.2 |
GO:0043922 |
negative regulation by host of viral transcription(GO:0043922) |
| 0.1 |
0.5 |
GO:0046839 |
phospholipid dephosphorylation(GO:0046839) |
| 0.1 |
0.7 |
GO:0042340 |
keratan sulfate catabolic process(GO:0042340) |
| 0.1 |
0.2 |
GO:0071600 |
otic vesicle morphogenesis(GO:0071600) |
| 0.1 |
0.3 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 0.1 |
2.0 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.1 |
1.3 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.1 |
0.4 |
GO:0035082 |
axoneme assembly(GO:0035082) |
| 0.1 |
0.5 |
GO:0019441 |
tryptophan catabolic process to kynurenine(GO:0019441) |
| 0.1 |
0.3 |
GO:1904578 |
response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
| 0.1 |
0.2 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 0.1 |
0.8 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.1 |
0.2 |
GO:0038155 |
interleukin-23-mediated signaling pathway(GO:0038155) |
| 0.0 |
0.3 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.0 |
0.9 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.0 |
0.1 |
GO:1901386 |
negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 0.0 |
0.2 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.0 |
0.8 |
GO:0097066 |
response to thyroid hormone(GO:0097066) |
| 0.0 |
1.0 |
GO:0002021 |
response to dietary excess(GO:0002021) |
| 0.0 |
0.1 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
| 0.0 |
0.7 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.0 |
0.1 |
GO:0051005 |
negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.0 |
0.2 |
GO:0071918 |
urea transmembrane transport(GO:0071918) |
| 0.0 |
0.1 |
GO:1901656 |
glycoside transport(GO:1901656) |
| 0.0 |
0.2 |
GO:0010324 |
membrane invagination(GO:0010324) |
| 0.0 |
0.1 |
GO:0007538 |
primary sex determination(GO:0007538) |
| 0.0 |
1.2 |
GO:0006636 |
unsaturated fatty acid biosynthetic process(GO:0006636) |
| 0.0 |
0.1 |
GO:0038007 |
netrin-activated signaling pathway(GO:0038007) |
| 0.0 |
0.8 |
GO:0002228 |
natural killer cell mediated immunity(GO:0002228) |
| 0.0 |
0.1 |
GO:0021545 |
cranial nerve development(GO:0021545) |
| 0.0 |
0.0 |
GO:0007320 |
insemination(GO:0007320) |
| 0.0 |
0.6 |
GO:0001702 |
gastrulation with mouth forming second(GO:0001702) |
| 0.0 |
0.1 |
GO:0060380 |
regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
| 0.0 |
0.1 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.0 |
0.1 |
GO:0003139 |
secondary heart field specification(GO:0003139) |
| 0.0 |
0.2 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.0 |
0.1 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.0 |
0.2 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.0 |
0.0 |
GO:0008210 |
estrogen metabolic process(GO:0008210) |
| 0.0 |
0.2 |
GO:0042759 |
long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.0 |
0.3 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.0 |
0.1 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.0 |
0.2 |
GO:0045950 |
negative regulation of mitotic recombination(GO:0045950) |
| 0.0 |
0.4 |
GO:0017187 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.0 |
0.1 |
GO:0035356 |
cellular triglyceride homeostasis(GO:0035356) |
| 0.0 |
0.2 |
GO:1904995 |
negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 0.0 |
0.3 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.0 |
0.1 |
GO:0044026 |
DNA hypermethylation(GO:0044026) |
| 0.0 |
0.3 |
GO:0090336 |
positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.0 |
0.2 |
GO:0001510 |
RNA methylation(GO:0001510) |
| 0.0 |
0.0 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) vesicle uncoating(GO:0072319) |
| 0.0 |
0.3 |
GO:0044331 |
cell-cell adhesion mediated by cadherin(GO:0044331) |
| 0.0 |
0.3 |
GO:0002370 |
natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) positive regulation of natural killer cell cytokine production(GO:0002729) positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
| 0.0 |
0.7 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.0 |
0.1 |
GO:0002001 |
renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) |
| 0.0 |
0.1 |
GO:0038086 |
VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
| 0.0 |
0.4 |
GO:0018065 |
protein lipoylation(GO:0009249) protein-cofactor linkage(GO:0018065) |
| 0.0 |
0.1 |
GO:0042335 |
cuticle development(GO:0042335) |
| 0.0 |
0.2 |
GO:0072429 |
response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.0 |
0.1 |
GO:0042214 |
terpene metabolic process(GO:0042214) |
| 0.0 |
0.3 |
GO:1990035 |
calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.0 |
0.1 |
GO:0015746 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.0 |
0.4 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.0 |
0.5 |
GO:0015695 |
organic cation transport(GO:0015695) |
| 0.0 |
1.4 |
GO:0050710 |
negative regulation of cytokine secretion(GO:0050710) |
| 0.0 |
0.1 |
GO:0051758 |
homologous chromosome movement towards spindle pole involved in homologous chromosome segregation(GO:0051758) |
| 0.0 |
0.7 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.0 |
0.1 |
GO:0007008 |
outer mitochondrial membrane organization(GO:0007008) |
| 0.0 |
0.1 |
GO:0006195 |
purine nucleotide catabolic process(GO:0006195) |
| 0.0 |
0.4 |
GO:0021615 |
glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.0 |
0.3 |
GO:1902035 |
positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.0 |
0.2 |
GO:0032099 |
negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.0 |
0.3 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 0.0 |
1.0 |
GO:0070206 |
protein trimerization(GO:0070206) |
| 0.0 |
0.3 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.0 |
0.3 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.0 |
1.1 |
GO:0014047 |
glutamate secretion(GO:0014047) |
| 0.0 |
0.0 |
GO:0070296 |
sarcoplasmic reticulum calcium ion transport(GO:0070296) |
| 0.0 |
0.1 |
GO:0000454 |
snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.0 |
0.1 |
GO:1902746 |
regulation of lens fiber cell differentiation(GO:1902746) |
| 0.0 |
0.6 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.0 |
0.4 |
GO:0046548 |
retinal rod cell development(GO:0046548) |
| 0.0 |
0.2 |
GO:0001915 |
negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 0.0 |
1.3 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.0 |
0.0 |
GO:0019060 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.0 |
0.0 |
GO:0032070 |
regulation of deoxyribonuclease activity(GO:0032070) |
| 0.0 |
0.3 |
GO:0050862 |
positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.0 |
0.2 |
GO:0044062 |
regulation of excretion(GO:0044062) |
| 0.0 |
0.1 |
GO:0033693 |
neurofilament bundle assembly(GO:0033693) |
| 0.0 |
0.4 |
GO:0045907 |
positive regulation of vasoconstriction(GO:0045907) |
| 0.0 |
0.2 |
GO:0071440 |
regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.0 |
0.3 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.0 |
0.2 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.0 |
0.4 |
GO:2000622 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.0 |
0.1 |
GO:0003228 |
atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
| 0.0 |
0.0 |
GO:0070585 |
protein localization to mitochondrion(GO:0070585) |
| 0.0 |
0.4 |
GO:0045576 |
mast cell activation(GO:0045576) |
| 0.0 |
0.1 |
GO:0051775 |
response to redox state(GO:0051775) |
| 0.0 |
0.3 |
GO:0038042 |
dimeric G-protein coupled receptor signaling pathway(GO:0038042) regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.0 |
0.2 |
GO:0050910 |
detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.0 |
3.0 |
GO:0006635 |
fatty acid beta-oxidation(GO:0006635) |
| 0.0 |
0.7 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.0 |
0.4 |
GO:1903056 |
regulation of melanosome organization(GO:1903056) |
| 0.0 |
0.7 |
GO:0035116 |
embryonic hindlimb morphogenesis(GO:0035116) |
| 0.0 |
0.1 |
GO:0048022 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.0 |
0.1 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.0 |
0.1 |
GO:0032971 |
regulation of muscle filament sliding(GO:0032971) |
| 0.0 |
0.3 |
GO:1902416 |
positive regulation of mRNA binding(GO:1902416) |
| 0.0 |
0.1 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 0.0 |
0.5 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.0 |
0.5 |
GO:0071542 |
dopaminergic neuron differentiation(GO:0071542) |
| 0.0 |
0.1 |
GO:0060285 |
cilium-dependent cell motility(GO:0060285) |
| 0.0 |
0.1 |
GO:0046010 |
positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
| 0.0 |
0.0 |
GO:1902527 |
positive regulation of protein monoubiquitination(GO:1902527) |
| 0.0 |
0.2 |
GO:0072093 |
ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
| 0.0 |
0.6 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.0 |
0.0 |
GO:0070232 |
regulation of T cell apoptotic process(GO:0070232) |
| 0.0 |
0.4 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 |
0.4 |
GO:0050860 |
negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.0 |
0.2 |
GO:0090500 |
endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.0 |
0.1 |
GO:0071313 |
cellular response to caffeine(GO:0071313) |
| 0.0 |
0.0 |
GO:0002414 |
immunoglobulin transcytosis in epithelial cells(GO:0002414) |
| 0.0 |
0.1 |
GO:0006544 |
glycine metabolic process(GO:0006544) |
| 0.0 |
0.5 |
GO:0071397 |
cellular response to cholesterol(GO:0071397) |
| 0.0 |
0.4 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.0 |
0.2 |
GO:0002430 |
complement receptor mediated signaling pathway(GO:0002430) |
| 0.0 |
0.3 |
GO:0060716 |
labyrinthine layer blood vessel development(GO:0060716) |
| 0.0 |
0.1 |
GO:0007528 |
neuromuscular junction development(GO:0007528) |
| 0.0 |
0.7 |
GO:0090004 |
positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.0 |
0.1 |
GO:0051354 |
negative regulation of oxidoreductase activity(GO:0051354) |
| 0.0 |
0.1 |
GO:0014904 |
myotube cell development(GO:0014904) |
| 0.0 |
0.1 |
GO:1990668 |
peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane(GO:1990668) |
| 0.0 |
0.1 |
GO:2001028 |
positive regulation of endothelial cell chemotaxis(GO:2001028) |
| 0.0 |
0.2 |
GO:0034447 |
very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.0 |
0.1 |
GO:0033690 |
positive regulation of osteoblast proliferation(GO:0033690) |
| 0.0 |
0.2 |
GO:0051149 |
positive regulation of muscle cell differentiation(GO:0051149) |
| 0.0 |
0.1 |
GO:0033599 |
regulation of mammary gland epithelial cell proliferation(GO:0033599) |
| 0.0 |
0.1 |
GO:0014911 |
positive regulation of smooth muscle cell migration(GO:0014911) |
| 0.0 |
0.2 |
GO:0006111 |
regulation of gluconeogenesis(GO:0006111) |
| 0.0 |
0.3 |
GO:0050999 |
regulation of nitric-oxide synthase activity(GO:0050999) |
| 0.0 |
0.1 |
GO:2000171 |
negative regulation of dendrite development(GO:2000171) |
| 0.0 |
0.3 |
GO:0010867 |
positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.0 |
0.1 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.0 |
0.2 |
GO:0052805 |
histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
| 0.0 |
0.1 |
GO:0042701 |
progesterone secretion(GO:0042701) |
| 0.0 |
0.9 |
GO:0006198 |
cAMP catabolic process(GO:0006198) |
| 0.0 |
0.1 |
GO:1904220 |
regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.0 |
0.1 |
GO:0033210 |
leptin-mediated signaling pathway(GO:0033210) |
| 0.0 |
0.4 |
GO:0032785 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 0.0 |
0.3 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.0 |
0.1 |
GO:1900186 |
negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.0 |
0.5 |
GO:0006244 |
pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.0 |
0.1 |
GO:0071025 |
RNA surveillance(GO:0071025) |
| 0.0 |
0.1 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.0 |
0.2 |
GO:0055070 |
copper ion homeostasis(GO:0055070) |
| 0.0 |
0.2 |
GO:0045076 |
regulation of interleukin-2 biosynthetic process(GO:0045076) |
| 0.0 |
0.1 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.0 |
0.1 |
GO:0051387 |
negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.0 |
0.2 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.0 |
0.1 |
GO:1904936 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.0 |
0.1 |
GO:0086018 |
SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) |
| 0.0 |
0.1 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 0.0 |
0.1 |
GO:0042136 |
neurotransmitter biosynthetic process(GO:0042136) |
| 0.0 |
0.1 |
GO:0016260 |
selenocysteine biosynthetic process(GO:0016260) |
| 0.0 |
0.5 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.0 |
0.2 |
GO:0045137 |
development of primary sexual characteristics(GO:0045137) |
| 0.0 |
0.3 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.0 |
0.1 |
GO:2000741 |
positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 0.0 |
0.2 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.0 |
0.2 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
| 0.0 |
0.2 |
GO:0001505 |
regulation of neurotransmitter levels(GO:0001505) |
| 0.0 |
0.0 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.0 |
0.1 |
GO:0007262 |
STAT protein import into nucleus(GO:0007262) |
| 0.0 |
0.0 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.0 |
0.1 |
GO:0061046 |
foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
| 0.0 |
0.2 |
GO:1900115 |
extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.0 |
0.1 |
GO:0051590 |
positive regulation of neurotransmitter transport(GO:0051590) |
| 0.0 |
0.0 |
GO:0072014 |
proximal tubule development(GO:0072014) |
| 0.0 |
0.2 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.0 |
0.1 |
GO:1902159 |
transepithelial water transport(GO:0035377) regulation of cyclic nucleotide-gated ion channel activity(GO:1902159) positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
| 0.0 |
0.0 |
GO:0042418 |
epinephrine biosynthetic process(GO:0042418) |
| 0.0 |
0.2 |
GO:0030728 |
ovulation(GO:0030728) |
| 0.0 |
0.1 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
| 0.0 |
0.3 |
GO:0034219 |
carbohydrate transmembrane transport(GO:0034219) |
| 0.0 |
0.4 |
GO:0006536 |
glutamate metabolic process(GO:0006536) |
| 0.0 |
0.4 |
GO:0044705 |
mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
| 0.0 |
0.0 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.0 |
0.1 |
GO:1902661 |
positive regulation of glucose mediated signaling pathway(GO:1902661) |
| 0.0 |
0.0 |
GO:0086091 |
regulation of heart rate by cardiac conduction(GO:0086091) |
| 0.0 |
0.1 |
GO:2001022 |
positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.0 |
0.1 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.0 |
0.1 |
GO:0046351 |
sucrose biosynthetic process(GO:0005986) disaccharide biosynthetic process(GO:0046351) |
| 0.0 |
0.1 |
GO:0070306 |
lens fiber cell differentiation(GO:0070306) |
| 0.0 |
0.0 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.0 |
1.0 |
GO:0034314 |
Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.0 |
0.3 |
GO:0031054 |
pre-miRNA processing(GO:0031054) |
| 0.0 |
0.2 |
GO:0018904 |
ether metabolic process(GO:0018904) |
| 0.0 |
0.1 |
GO:0010453 |
regulation of cell fate commitment(GO:0010453) |
| 0.0 |
0.2 |
GO:0006591 |
ornithine metabolic process(GO:0006591) |
| 0.0 |
1.3 |
GO:0036498 |
IRE1-mediated unfolded protein response(GO:0036498) |
| 0.0 |
0.1 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.0 |
0.1 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.0 |
0.0 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.0 |
0.1 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.0 |
0.1 |
GO:0060046 |
regulation of acrosome reaction(GO:0060046) |
| 0.0 |
0.2 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.0 |
0.1 |
GO:0035459 |
cargo loading into vesicle(GO:0035459) |
| 0.0 |
0.2 |
GO:0006554 |
lysine catabolic process(GO:0006554) |
| 0.0 |
0.1 |
GO:0046643 |
regulation of gamma-delta T cell activation(GO:0046643) |
| 0.0 |
0.3 |
GO:0048169 |
regulation of long-term neuronal synaptic plasticity(GO:0048169) |
| 0.0 |
0.3 |
GO:0043153 |
entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.0 |
0.1 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.0 |
0.0 |
GO:0046532 |
regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.0 |
1.7 |
GO:0050911 |
detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.0 |
0.1 |
GO:0055072 |
iron ion homeostasis(GO:0055072) |
| 0.0 |
0.0 |
GO:0030718 |
germ-line stem cell population maintenance(GO:0030718) |
| 0.0 |
0.1 |
GO:0007625 |
grooming behavior(GO:0007625) |
| 0.0 |
0.0 |
GO:0030823 |
regulation of cGMP metabolic process(GO:0030823) |
| 0.0 |
0.4 |
GO:0016254 |
preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.0 |
0.1 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.0 |
0.1 |
GO:0051560 |
mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.0 |
0.1 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 0.0 |
0.2 |
GO:0035435 |
phosphate ion transmembrane transport(GO:0035435) |
| 0.0 |
0.1 |
GO:0071300 |
cellular response to retinoic acid(GO:0071300) |
| 0.0 |
0.2 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.0 |
0.3 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.0 |
0.1 |
GO:0044208 |
'de novo' AMP biosynthetic process(GO:0044208) |
| 0.0 |
0.0 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.0 |
0.1 |
GO:0001865 |
NK T cell differentiation(GO:0001865) |
| 0.0 |
0.1 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 0.0 |
0.1 |
GO:0036315 |
cellular response to sterol(GO:0036315) |
| 0.0 |
0.1 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
| 0.0 |
0.2 |
GO:0098743 |
cell aggregation(GO:0098743) |
| 0.0 |
0.0 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.0 |
0.1 |
GO:0019627 |
urea metabolic process(GO:0019627) nitrogen cycle metabolic process(GO:0071941) |
| 0.0 |
0.3 |
GO:0019935 |
cyclic-nucleotide-mediated signaling(GO:0019935) |
| 0.0 |
0.2 |
GO:0050974 |
detection of mechanical stimulus involved in sensory perception(GO:0050974) |
| 0.0 |
0.1 |
GO:0042428 |
serotonin metabolic process(GO:0042428) |
| 0.0 |
0.1 |
GO:0021902 |
forebrain neuron fate commitment(GO:0021877) commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.0 |
0.1 |
GO:0098734 |
macromolecule depalmitoylation(GO:0098734) |
| 0.0 |
0.1 |
GO:0001659 |
temperature homeostasis(GO:0001659) |
| 0.0 |
0.1 |
GO:0071398 |
cellular response to fatty acid(GO:0071398) |
| 0.0 |
0.2 |
GO:0032469 |
endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.0 |
0.0 |
GO:0050764 |
regulation of phagocytosis(GO:0050764) |
| 0.0 |
0.0 |
GO:0034135 |
regulation of toll-like receptor 2 signaling pathway(GO:0034135) |
| 0.0 |
0.2 |
GO:0035640 |
exploration behavior(GO:0035640) |
| 0.0 |
0.2 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.0 |
0.0 |
GO:2000660 |
negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.0 |
0.1 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.0 |
0.1 |
GO:0032119 |
sequestering of zinc ion(GO:0032119) |
| 0.0 |
0.0 |
GO:0032986 |
nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
| 0.0 |
0.6 |
GO:0080171 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.0 |
0.2 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.0 |
0.0 |
GO:0014883 |
transition between fast and slow fiber(GO:0014883) |
| 0.0 |
0.1 |
GO:0051926 |
negative regulation of calcium ion transport(GO:0051926) |
| 0.0 |
0.0 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.0 |
0.0 |
GO:0003170 |
heart valve development(GO:0003170) |
| 0.0 |
0.1 |
GO:0009125 |
nucleoside monophosphate catabolic process(GO:0009125) |
| 0.0 |
0.0 |
GO:0045006 |
DNA deamination(GO:0045006) DNA cytosine deamination(GO:0070383) |
| 0.0 |
0.1 |
GO:0030311 |
poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.0 |
0.1 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.0 |
0.3 |
GO:0006298 |
mismatch repair(GO:0006298) |
| 0.0 |
0.0 |
GO:0014888 |
striated muscle adaptation(GO:0014888) |
| 0.0 |
0.2 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.0 |
0.1 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
